NCT02171676View on ClinicalTrials.gov

BIBW 2992 After Administration of Docetaxel in Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

March 31, 2008

Conditions
Neoplasms
Interventions
DRUG

Docetaxel

DRUG

BIBW 2992

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY